Rockbridge Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Rockbridge Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-644	Closed	-$33K	–	184
2023 Q4	$33K	Buy	+644	New	+$33.8K	0.01%	279
2022 Q3	–	Sell	-791	Closed	-$60.9K	–	167
2022 Q2	$60.9K	Sell	791 -425	-35%	-$32.4K	0.01%	200
2022 Q1	$89.8K	Sell	1,216 -470	-28%	-$31.6K	0.01%	229
2021 Q4	$105K	Hold	1,686	–	–	0.02%	249
2021 Q3	$100K	Buy	1,686 +600	+55%	+$39.5K	0.02%	234
2021 Q2	$73K	Buy	1,086 +100	+10%	+$6.52K	0.01%	262
2021 Q1	$62K	Sell	986 -1,300	-57%	-$80.9K	0.01%	267
2020 Q4	$142K	Hold	2,286	–	–	0.03%	165
2020 Q3	$138K	Hold	2,286	–	–	0.03%	153
2020 Q2	$134K	Buy	+2,286	New	+$137K	0.03%	149

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rockbridge Investment Management's BMY Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 644 shares — an estimated $33K sold.

Rockbridge Investment Management first reported a position in BMY in Q2 2020 and held it in 10 quarters. The position peaked at $142K in Q4 2020. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Rockbridge Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Rockbridge Investment Management sold 644 Bristol-Myers Squibb shares in Q1 2024, an estimated $33K.
Rockbridge Investment Management first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 10 quarters.
Rockbridge Investment Management's Bristol-Myers Squibb position peaked at $142K in Q4 2020.
2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.